Meridian Bioscience reported $49.77M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 35.72M 8.86M
Atrion ATRI:US 23.66M 6.59M
Becton, Dickinson and BDX:US $ 2283M 870M
Bio Rad Laboratories BIO:US $ 859.9M 127.07M
Cerulean Pharma CERU:US $ 45.57M 36.46M
Cerus CERS:US $ 78.46M 19.43M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Luminex LMNX:US $ 271.56M 37.85M
Meridian Bioscience VIVO:US $ 49.77M 48.75M
Myriad Genetics MYGN:US $ 295.2M 176.8M
Neogen NEOG:US $ 71.28M 4.32M
Orasure Technologies OSUR:US $ 134.96M 23.16M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Quidel QDEL:US $ 578.45M 14.78M
Rockwell Medical RMTI:US $ 23.39M 8.99M
Sientra SIEN:US $ 66.13M 16.29M
Staar Surgical STAA:US $ 196.25M 23.16M
Thermo Fisher Scientific TMO:US $ 12027M 5004M
Trinity Biotech TRIB:US $ 28.62M 3.66M
Utah Medical Products UTMD:US $ 64.32M 8.29M